Inventor · disambiguated record
Daniel Starczynowski
Also filed as: STARCZYNOWSKI DANIEL · STARCZYNOWSKI DANIEL T
8 granted patents·8 pending applications·57 citations·filing 2014–2023
85Inventor score
Files withCHILDRENS HOSPITAL MED CT13CHILDREN'S HOSPITAL MEDICAL CENTER2CHILDRENS HOSP MEDICAL CENTER1
Top patents by PatentIndex Score
16 records- 0194US9855273B2Combination therapy for MDSCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2016·Granted Jan 2, 2018·20 cites·10 claims
- 0293US9168257B2Combination therapy for MDSCHILDRENS HOSP MEDICAL CENTER·Filed 2014·Granted Oct 27, 2015·16 cites·29 claims
- 0392US11542261B2Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitorsCHILDRENS HOSPITAL MED CT·Filed 2020·Granted Jan 3, 2023·9 cites·19 claims
- 0492US9504706B2Combination therapy for MDSCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2015·Granted Nov 29, 2016·8 cites·20 claims
- 0575US11547696B2Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemiasCHILDRENS HOSPITAL MED CT·Filed 2017·Granted Jan 10, 2023·2 cites·9 claims
- 0670US11752136B2Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemiasCHILDRENS HOSPITAL MED CT·Filed 2022·Granted Sep 12, 2023·0 cites·10 claims
- 0768US10487329B2Methods and compositions for the treatment of head and neck cancerCHILDRENS HOSPITAL MED CT·Filed 2016·Granted Nov 26, 2019·2 cites·11 claims
- 0862US2022235042A1Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 InhibitorsCHILDRENS HOSPITAL MED CT·Filed 2022·Application pending·0 cites
- 0958US2025368648A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2023·Application pending·0 cites
- 1052US2022213094A1Substituted Imidazo[l,2-a]-pyridines as IRAK 1/4 and FLT3 InhibitorsCHILDRENS HOSPITAL MED CT·Filed 2022·Application pending·0 cites
- 1152US2024294530A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 1251US2025154144A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2022·Application pending·0 cites
- 1347US2022267753A1Rational therapeutic targeting of oncogenic immune signaling states in myeloid malignancies via the ubiquitin conjugating enzyme ube2nCHILDRENS HOSPITAL MED CT·Filed 2020·Application pending·0 cites
- 1445US2023303563A1Multi-cyclic irak and flt3 inhibiting compounds and uses thereofCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 1541US2021292843A1Treatment of diseases associated with activated irakCHILDRENS HOSPITAL MED CT·Filed 2017·Application pending·0 cites
- 1636US11254667B2Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitorsCHILDRENS HOSPITAL MED CT·Filed 2017·Granted Feb 22, 2022·0 cites·38 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Starczynowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →